blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3990456

EP3990456 - CXCR4 INHIBITORS AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.04.2024
Database last updated on 11.09.2024
FormerRequest for examination was made
Status updated on  02.04.2022
FormerThe international publication has been made
Status updated on  15.01.2021
Most recent event   Tooltip27.04.2024Application deemed to be withdrawnpublished on 29.05.2024  [2024/22]
Applicant(s)For all designated states
X4 Pharmaceuticals, Inc.
955 Massachusetts Avenue 4th Floor
Cambridge, Massachusetts 02139 / US
[2022/18]
Inventor(s)01 / BOURQUE, Elyse Marie Josee
162 Ch Bouffard
L'Etang-du-Nord Québec G4T3G6 / CA
02 / SKERLJ, Renato
12 Crocker Circle
West Newton, Massachusetts 02465 / US
 [2022/18]
Representative(s)Tostmann, Holger Carl
Wallinger Ricker Schlotter Tostmann
Patent- und Rechtsanwälte Partnerschaft mbB
Zweibrückenstrasse 5-7
80331 München / DE
[2022/18]
Application number, filing date20830551.626.06.2020
[2022/18]
WO2020US39816
Priority number, dateUS201962867003P26.06.2019         Original published format: US 201962867003 P
[2022/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020264292
Date:30.12.2020
Language:EN
[2020/53]
Type: A1 Application with search report 
No.:EP3990456
Date:04.05.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.2020 takes the place of the publication of the European patent application.
[2022/18]
Search report(s)International search report - published on:US30.12.2020
ClassificationIPC:C07D471/04, C07D519/00
[2022/18]
CPC:
A61P35/00 (EP); A61P31/00 (EP); C07D401/14 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/18]
TitleGerman:CXCR4-INHIBITOREN UND VERWENDUNGEN DAVON[2022/18]
English:CXCR4 INHIBITORS AND USES THEREOF[2022/18]
French:INHIBITEURS DE CXCR4 ET LEURS UTILISATIONS[2022/18]
Entry into regional phase21.12.2021National basic fee paid 
21.12.2021Search fee paid 
21.12.2021Designation fee(s) paid 
21.12.2021Examination fee paid 
Examination procedure21.12.2021Examination requested  [2022/18]
13.08.2022Loss of particular rights, legal effect: Claims
06.09.2022Despatch of communication of loss of particular rights: Claims {1}
03.01.2024Application deemed to be withdrawn, date of legal effect  [2024/22]
01.02.2024Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/22]
Fees paidRenewal fee
27.06.2022Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.06.202304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2005059702  (BRIDGER GARY J [US], et al) [A] 1-3 , 23 * , entire document *;
 [X]US2005154201  (CHEN GANG [CA], et al) [X] 1, 23 * , especially para [0021] and para [0062]-[0066] *;
 [A]WO2017223229  (X4 PHARMACEUTICALS INC [US]) [A] 1-3, 23* , entire document *;
 [X]  - Anonymous, "Compound Summary for CID68972701", PubChem Compound, (20121130), Database accession no. CID68972701, URL: NCBI, XP055780389 [X] 1-3 * , especially p.2 formula *
 [A]  - Anonymous, "Compound Summary for CID68971863", PubChem COMPOUND, (20121130), Database accession no. CID68971863, URL: NCBI, XP055780391 [A] 1-3 * , especially p.2 formula *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.